BioSpace News Archive

NEC Iris Recognition Technology Ranks First in NIST Accuracy Testing

NEC Corporation announced that its iris recognition technology achieved the highest matching accuracy evaluation in the recent Iris Exchange (IREX,*1) IX evaluations of automated iris recognition algorithms performed by the U.S. National Institute of Standards and Technology (NIST).

April 26, 2018

·

2 min read

Business

Medline Expands Footprint in Texas with Opening of Surgical Procedure Tray Manufacturing Facility in Laredo

Medline today announced the opening of a 250,000-square foot manufacturing facility in the Killam Industrial Park in Laredo, Texas.

April 26, 2018

·

2 min read

Job Trends

Avella Releases New Report on Anticipated Specialty Medication Approvals

Avella has just announced the release of a 16-page report detailing the specialty drug pipeline, including all of the latest medications expected to receive FDA approval within the coming months.

April 26, 2018

·

3 min read

Drug Development

MDxHealth Announces Positive Clinical Updates for ConfirmMDx

MDxHealth SA announces two positive clinical developments for its ConfirmMDx for prostate cancer test.

April 26, 2018

·

5 min read

Policy

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Edge Therapeutics, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Edge Therapeutics, Inc. violated federal securities laws.

April 26, 2018

·

1 min read

Biotech Bay

Guardant Health Publishes Extensive Validation of Guardant360® Assay Comprising Largest-Published Blood-Tissue Comparison

The largest published comparison of comprehensive liquid biopsy results to tissue genotyping demonstrated high positive predictive value for the Guardant360 assay, Guardant Health announced.

April 26, 2018

·

2 min read

BioMidwest

2018 Hospital Merger and Acquisition Activity Continues Rapid Pace with 30 Announced Transactions in the First Quarter

Hospital and health system partnership transactions are continuing at a brisk pace in 2018.

April 26, 2018

·

4 min read

Biotech Bay

Blue Shield of California on Track to Reduce Opioid Use Among Members by 50 Percent by End of 2018

The overall consumption of opioids among Blue Shield of California members with non-cancer pain has fallen by 42 percent since the nonprofit health plan launched its Narcotic Safety Initiative in 2015 to help solve the public health epidemic.

April 26, 2018

·

3 min read

Pharm Country

CDC estimate on autism prevalence increases 15 percent, to 1 in 59 children

The Centers for Disease Control and Prevention (CDC) today released its biennial update of autism’s estimated prevalence among the nation’s children, based on an analysis of 2014 medical and/or school records of 8-year-olds from 11 monitoring sites across the United States.

April 26, 2018

·

4 min read

FDA

FDA Grants Breakthrough Therapy Designation to Omeros’ MASP-2 Inhibitor OMS721 for the Treatment of High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Omeros Corporation announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to OMS721 for the treatment of patients with high-risk hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).

April 26, 2018

·

10 min read